Care of HIV patients with chronic hepatitis B: updated recommendations from the HIV-Hepatitis B Virus International Panel

被引：131

作者：

Soriano, Vincent ^{[1
]}

Puoti, Massimo ^{[2
]}

Peters, Marion ^{[3
]}

Renhamou, Yves ^{[4
]}

Sulkowski, Mark ^{[5
]}

Zoulim, Fabien ^{[6
]}

Mauss, Stefan ^{[7
]}

Rockstroh, Juergen ^{[8
]}

机构：

[1] Hosp Carlos III, Dept Infect Dis, Madrid 28029, Spain

[2] Univ Hosp, Dept Infect Dis, Brescia, Italy

[3] Univ Calif San Francisco, Hepatol Unit, San Francisco, CA 94143 USA

[4] Hop La Pitie Salpetriere, Dept Hepatol, Paris, France

[5] Johns Hopkins Med Inst, Viral Hepatitis Ctr, Baltimore, MD 21205 USA

[6] Univ Lyon 1, Hospices Civils Lyon, INSERM, U871, F-69365 Lyon, France

[7] Ctr HIV & Hepatogastroenterol, Dusseldorf, Germany

[8] Univ Hosp, Dept Med 1, Bonn, Germany

来源：

AIDS | 2008年 / 22卷 / 12期

关键词：

drug resistance; hepatitis B; hepatitis B virus; HIV; liver; tenofovir;

D O I：

10.1097/QAD.0b013e3282f8b46f

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

Nearly 10% of the estimated 36 million people having HIV worldwide suffer from chronic hepatitis B virus (HBV) infection. The advent of new antiviral agents against HBV and the recent availability of improved molecular diagnostic tools have revolutioned the management of HIV/HBV coinfected patients. The present study represents an update of the current knowledge about HBV/HIV coinfection and an intent to provide practical advise about how to give the best care to HIV-infected persons with chronic hepatitis B. (C) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.

引用

页码：1399 / 1410

页数：12

共 155 条

[1]

Aceti A, 2002, J ACQ IMMUN DEF SYND, V29, P41, DOI 10.1097/00042560-200201010-00005

[2]

Early detection of viral resistance by determination of hepatitis B virus polymerase mutations in patients treated by lamivudine for chronic hepatitis B [J].

Ahmed, SNS ;

Tavan, D ;

Pichoud, C ;

Berby, F ;

Stuyver, L ;

Johnson, M ;

Merle, P ;

Abidi, H ;

Trépo, C ;

Zoulim, F .

HEPATOLOGY, 2000, 32 (05) :1078-1088

[3]

Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV co-infected patients [J].

Alberti, A ;

Clumeck, N ;

Collins, S ;

Gerlich, W ;

Lundgren, J ;

Palù, G ;

Reiss, P ;

Thiebaut, R ;

Weiland, O ;

Yazdanpanah, Y ;

Zeuzem, S .

JOURNAL OF HEPATOLOGY, 2005, 42 (05) :615-624

[4]

Epidemiology of viral hepatitis and HIV co-infection [J].

Alter, MJ .

JOURNAL OF HEPATOLOGY, 2006, 44 :S6-S9

[5]

Dooley Samuel W., 2008, Morbidity and Mortality Weekly Report, V57, P1

[6]

[Anonymous], GUID US ANT AG HIV 1

[7]

Influence of liver fibrosis on highly active antiretroviral therapy-associated hepatotoxicity in patients with HIV and hepatitis C virus coinfection [J].

Aranzabal, L ;

Casado, JL ;

Moya, J ;

Quereda, C ;

Diz, S ;

Moreno, A ;

Moreno, L ;

Antela, A ;

Perez-Elías, MJ ;

Dronda, F ;

Marín, A ;

Hernandez-Ranz, F ;

Moreno, A ;

Moreno, S .

CLINICAL INFECTIOUS DISEASES, 2005, 40 (04) :588-593

[8]

Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain [J].

Arribas, JR ;

González-García, JJ ;

Lorenzo, A ;

Montero, D ;

de Guevara, CL ;

Montes, A ;

Hernández, S ;

Pacheco, R ;

Peña, JM ;

Vázquez, JJ .

AIDS, 2005, 19 (13) :1361-1365

[9]

Emtricitabine - An antiretroviral agent for HIV infection [J].

Bang, LM ;

Scott, LJ .

DRUGS, 2003, 63 (22) :2413-2424

[10]

Barreiro P, 2004, AIDS REV, V6, P234

← 1 2 3 4 5 6 7 8 9 10 →